NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

No, the partial halt started in August of that year, late in 2015, not all of 2015. And it doesn’t say they stopped enrolling as of that date. It says the last 17… they did not need to expand the trial arm with basically no placebo arm… this is why they have an external control arm with many, many times the number of patients they could have enrolled.

And yes, likely with the advice of counsel and the regulators themselves, they waited for the FDA to roll out reformed policies that would make the pathway easier. They could have rushed it under the bad policies of the past, but that would have been immensely stupid. We were all here to watch all of it. It was immensely skillful and showed great thought and strategic foresight.

And yes, if you’re going to run a trial for OS, you actually have to measure SURVIVAL… that’s why it takes long. You don’t seem to understand what is going on here.

No, it doesn’t say they stopped from that day, it says they did not enroll the last 17, which was an expansion of the trial as well as the placebo patients.

As for the starting context, it was not with you. You jumped into the middle of a conversation not about “judging” others for lack of patience but discussing that some investments are better for different people and this investment is not for everyone. You took virtually all of it out of context with your diversion into the esoteric nature of short term trading volatility rather than understanding that this stock of course is wildly volatile and it can go way down, hard and fast, on any given day, or way up and sometimes it is up over a long time given the nature of early stage bios, where little happens over long periods of time.

Here below is where this started, not where you falsely suggest it started. How much more noise are you going to throw up here?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173739383